These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22473158)

  • 1. Is the pooled analysis of the north central cancer treatment group phase III trials N9741 and N9841 biased?
    Mandalà M; Grosso F
    J Clin Oncol; 2012 May; 30(15):1894-5; author reply 1895. PubMed ID: 22473158
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of colorectal cancer with peritoneal carcinomatosis: is a new staging necessary?
    Kesikli SA; Eren MF; Akgul Babacan N; Kilickap S
    J Clin Oncol; 2012 Jun; 30(18):2287-8; author reply 2288-9. PubMed ID: 22614990
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors dictating outcomes in patients with colorectal cancer and peritoneal carcinomatosis: selection, resection, or convection?
    Cercek A; Saltz L
    J Clin Oncol; 2012 Jan; 30(3):226-8. PubMed ID: 22162591
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin in colorectal cancer: current studies.
    Goldberg R
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):42-7. PubMed ID: 11204663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center.
    Park SY; Choi GS; Park JS; Kim HJ; Yang CS; Kim JG; Kang BW
    Ann Surg Oncol; 2016 Jul; 23(7):2266-73. PubMed ID: 26951148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-67.
    Sugarbaker PH
    J Surg Oncol; 2004 Dec; 88(4):276-8. PubMed ID: 15565559
    [No Abstract]   [Full Text] [Related]  

  • 8. [Totally implantable systems in colorectal tumors. The locoregional chemotherapy of hepatic and peritoneal metastases].
    Ciaccio V; Bufalari A; Ferri M; Giustozzi GM
    Minerva Chir; 1992 Apr; 47(7):621-5. PubMed ID: 1589121
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
    Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
    Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of peritoneal dissemination in patients with unresectable advanced or recurrent colorectal cancer who underwent curative resection after combination chemotherapy].
    Mizota S; Ikeda S; Yamauchi M; Imaoka Y; Mashima H; Okimoto S; Takakura Y; Noma M; Ohara M; Oishi K; Kohashi T; Fudaba Y; Ishimoto T; Matsugu Y; Nakahara H; Urushihara T; Shinozaki K; Itamoto T
    Gan To Kagaku Ryoho; 2014 May; 41(5):595-600. PubMed ID: 24917004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected Findings in a Patient With Cancer of Unknown Primary Syndrome.
    Lübbert C; Holler B
    Gastroenterology; 2018 Feb; 154(3):491-492. PubMed ID: 29352954
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
    Klaver YL; Simkens LH; Lemmens VE; Koopman M; Teerenstra S; Bleichrodt RP; de Hingh IH; Punt CJ
    Eur J Surg Oncol; 2012 Jul; 38(7):617-23. PubMed ID: 22572106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
    Zani S; Papalezova K; Stinnett S; Tyler D; Hsu D; Blazer DG
    J Surg Oncol; 2013 Mar; 107(4):307-11. PubMed ID: 22811275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases.
    Yun JA; Park Y; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    J Surg Oncol; 2014 Dec; 110(7):839-44. PubMed ID: 25043872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Oct; 18(11):1396, 1401, 1404 passim. PubMed ID: 15609469
    [No Abstract]   [Full Text] [Related]  

  • 17. Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.
    Hompes D; Boot H; van Tinteren H; Verwaal V
    J Surg Oncol; 2011 Sep; 104(3):269-73. PubMed ID: 21465492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials.
    Kerbel RS; Grothey A
    Nat Rev Clin Oncol; 2015 Jun; 12(6):313-4. PubMed ID: 25963090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resampling the N9741 trial to compare tumor dynamic versus conventional end points in randomized phase II trials.
    Sharma MR; Gray E; Goldberg RM; Sargent DJ; Karrison TG
    J Clin Oncol; 2015 Jan; 33(1):36-41. PubMed ID: 25349295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.